| Name | Title | Contact Details |
|---|
CNR Health Care Network is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our vision is to serve our communities’ evolving healthcare needs by cultivating a network of compassionate, dedicated professionals. We are committed to working together, using best practices, improving quality, and assuring an exceptional patient experience. Our highest priority is caring for people - the friends, family and neighbors whom we serve in our community. We are committed to providing an environment based on respect and one which encourages personal and profession growth.
Marshalltown Medical & Surgical Center (MMSC) is the only full service medical center in the area. The 125-bed, not-for-profit facility serves more than 60,000 residents with a wide variety of healthcare services and around-the-clock emergency care. MMSC includes a state-of-the-art Diagnostic Imaging Department, Cardiac Catheterization Lab and Rehabilitation Center, as well as four primary care clinics. The hospital is accredited by the Center for Medicare and Medicaid Services (CMS).
Keune Haircosmetics is a Lawrenceville, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.